Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?

被引：9

作者：

Kantarjian, Hagop ^{[1
]}

Branford, Susan ^{[2
]}

Breccia, Massimo ^{[3
]}

Cortes, Jorge ^{[4
]}

Haddad, Fadi G. ^{[1
]}

Hochhaus, Andreas ^{[5
]}

Hughes, Timothy ^{[6
]}

Issa, Ghayas C. ^{[1
]}

Jabbour, Elias ^{[1
]}

Nicolini, Franck E. ^{[7
]}

Sasaki, Koji ^{[1
]}

Xavier-Mahon, Francois ^{[8
,9
]}

机构：

[1] MD Anderson Canc Ctr, Leukemia Dept, Madrid, Spain

[2] Ctr Canc Biol Australia, SA Pathol, Adelaide, SA, Australia

[3] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy

[4] Georgia Canc Ctr, Atlanta, GA 30303 USA

[5] Univ Klinikum Jena, Jena, Germany

[6] South Australian Hlth & Med Inst, SAHMRI, Adelaide, SA, Australia

[7] Ctr Leon Berard, CRCL, INSERM, Hematol Dept,U1052, Lyon, France

[8] Inst Bergonie Bergonie Inst 229 Cours Argonne, F-33076 Bordeaux, France

[9] Bordeaux Univ, INSERM, U1312, Bordeaux, France

来源：

LEUKEMIA | 2024年 / 38卷 / 05期

关键词：

CHRONIC MYELOGENOUS LEUKEMIA; EARLY MOLECULAR RESPONSE; ALPHA PLUS CYTARABINE; LONG-TERM OUTCOMES; INTERFERON-ALPHA; IMATINIB; BOSUTINIB; SURVIVAL; DISCONTINUATION; DASATINIB;

D O I：

10.1038/s41375-024-02229-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：947 / 950

页数：4

共 36 条

[1] Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML [J].

Branford, Susan ;

Yeung, David T. ;

Ross, David M. ;

Prime, Jodi A. ;

Field, Chani R. ;

Altamura, Haley K. ;

Yeoman, Alexandra L. ;

Georgievski, Jasmina ;

Jamison, Bronte A. ;

Phillis, Stuart ;

Sullivan, Brad ;

Briggs, Nancy E. ;

Hertzberg, Mark ;

Seymour, John F. ;

Reynolds, John ;

Hughes, Timothy P. .

BLOOD, 2013, 121 (19) :3818-3824

[2] Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial [J].

Brummendorf, Tim H. ;

Cortes, Jorge E. ;

Milojkovic, Dragana ;

Gambacorti-Passerini, Carlo ;

Clark, Richard E. ;

le Coutre, Philipp ;

Garcia-Gutierrez, Valentin ;

Chuah, Charles ;

Kota, Vamsi ;

Lipton, Jeffrey H. ;

Rousselot, Philippe ;

Mauro, Michael J. ;

Hochhaus, Andreas ;

Hurtado Monroy, Rafael ;

Leip, Eric ;

Purcell, Simon ;

Yver, Anne ;

Viqueira, Andrea ;

Deininger, Michael W. .

LEUKEMIA, 2022, 36 (07) :1825-1833

[3] Monitoring Molecular Response in Chronic Myeloid Leukemia [J].

Cortes, Jorge ;

Quintas-Cardama, Alfonso ;

Kantarjian, Hagop M. .

CANCER, 2011, 117 (06) :1113-1122

[4] Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial [J].

Cortes, Jorge E. ;

Gambacorti-Passerini, Carlo ;

Deininger, Michael W. ;

Mauro, Michael J. ;

Chuah, Charles ;

Kim, Dong-Wook ;

Dyagil, Irina ;

Glushko, Nataliia ;

Milojkovic, Dragana ;

le Coutre, Philipp ;

Garcia-Gutierrez, Valentin ;

Reilly, Laurence ;

Jeynes-Ellis, Allison ;

Leip, Eric ;

Bardy-Bouxin, Nathalie ;

Hochhaus, Andreas ;

Brummendorf, Tim H. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (03) :231-+

[5] Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial [J].

Cortes, Jorge E. ;

Saglio, Giuseppe ;

Kantarjian, Hagop M. ;

Baccarani, Michele ;

Mayer, Jiri ;

Boque, Concepcion ;

Shah, Neil P. ;

Chuah, Charles ;

Casanova, Luis ;

Bradley-Garelik, Brigid ;

Manos, George ;

Hochhaus, Andreas .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (20) :2333-U54

[6] Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial [J].

Cortes, Jorge E. ;

Kim, Dong-Wook ;

Kantarjian, Hagop M. ;

Bruemmendorf, Tim H. ;

Dyagil, Irina ;

Griskevicius, Laimonas ;

Malhotra, Hemant ;

Powell, Christine ;

Gogat, Karin ;

Countouriotis, Athena M. ;

Gambacorti-Passerini, Carlo .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) :3486-3492

[7] Navigating the Management of Chronic Phase CML in the Era of Generic BCR::ABL1 Tyrosine Kinase Inhibitors [J].

Haddad, Fadi G. ;

Kantarjian, Hagop .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (01)

[8] Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors [J].

Haddad, Fadi G. ;

Sasaki, Koji ;

Issa, Ghayas C. ;

Garcia-Manero, Guillermo ;

Ravandi, Farhad ;

Kadia, Tapan ;

Cortes, Jorge ;

Konopleva, Marina ;

Pemmaraju, Naveen ;

Alvarado, Yesid ;

Yilmaz, Musa ;

Borthakur, Gautam ;

DiNardo, Courtney ;

Jain, Nitin ;

Daver, Naval ;

Short, Nicholas J. ;

Jabbour, Elias ;

Kantarjian, Hagop .

AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (07) :856-864

[9] Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants [J].

Hehlmann, R. ;

Lauseker, M. ;

Saussele, S. ;

Pfirrmann, M. ;

Krause, S. ;

Kolb, H. J. ;

Neubauer, A. ;

Hossfeld, D. K. ;

Nerl, C. ;

Gratwohl, A. ;

Baerlocher, G. M. ;

Heim, D. ;

Bruemmendorf, T. H. ;

Fabarius, A. ;

Haferlach, C. ;

Schlegelberger, B. ;

Mueller, M. C. ;

Jeromin, S. ;

Proetel, U. ;

Kohlbrenner, K. ;

Voskanyan, A. ;

Rinaldetti, S. ;

Seifarth, W. ;

Spiess, B. ;

Balleisen, L. ;

Goebeler, M. C. ;

Haenel, M. ;

Ho, A. ;

Dengler, J. ;

Falge, C. ;

Kanz, L. ;

Kremers, S. ;

Burchert, A. ;

Kneba, M. ;

Stegelmann, F. ;

Koehne, C. A. ;

Lindemann, H. W. ;

Waller, C. F. ;

Pfreundschuh, M. ;

Spiekermann, K. ;

Berdel, W. E. ;

Mueller, L. ;

Edinger, M. ;

Mayer, J. ;

Beelen, D. W. ;

Bentz, M. ;

Link, H. ;

Hertenstein, B. ;

Fuchs, R. ;

Wernli, M. .

LEUKEMIA, 2017, 31 (11) :2398-2406

[10] Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia [J].

Hehlmann, Ruediger ;

Lauseker, Michael ;

Jung-Munkwitz, Susanne ;

Leitner, Armin ;

Mueller, Martin C. ;

Pletsch, Nadine ;

Proetel, Ulrike ;

Haferlach, Claudia ;

Schlegelberger, Brigitte ;

Balleisen, Leopold ;

Haenel, Mathias ;

Pfirrmann, Markus ;

Krause, Stefan W. ;

Nerl, Christoph ;

Pralle, Hans ;

Gratwohl, Alois ;

Hossfeld, Dieter K. ;

Hasford, Joerg ;

Hochhaus, Andreas ;

Saussele, Susanne .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (12) :1634-1642

← 1 2 3 4 →